Keystone meeting summary: ‘Adipogenesis, obesity, and inflammation’ and ‘Diabetes mellitus and the control of cellular energy metabolism, ’ January 21–26, 2006, Vancouver, Canada

  1. Silvia Corvera1,6,
  2. Alison Burkart1,
  3. Ja-Young Kim2,
  4. Jennifer Christianson1,
  5. Zhao Wang2, and
  6. Philipp E. Scherer2,3,4,5
  1. 1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA;
  2. 2Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA;
  3. 3Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA;
  4. 4Department of Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA

    Abstract

    The dysregulation of specific cellular functions in adipocytes, muscle cells, β cells, and the liver leads to changes in systemic metabolic processes and ultimately to the pathophysiological manifestations that cause type 2 diabetes. The underlying cellular mechanisms are complex. The two meetings summarized here aimed to highlight the recent advances in our understanding of the molecular basis of feeding and nutrient storage and on the molecular consequences of obesity in terms of promoting risk for type 2 diabetes and cardiovascular disease.

    Keywords

    Footnotes

    | Table of Contents

    G&D Most Read

    View all ...

    follow us on twitter

    Life Science Alliance